Literature DB >> 6859899

Anticentromere and anticentriole antibodies in the scleroderma spectrum.

D L Tuffanelli, F McKeon, D M Kleinsmith, T K Burnham, M Kirschner.   

Abstract

We studied serum samples from 106 patients, including 80 in the scleroderma spectrum, by indirect immunofluorescent microscopy, using PtK1 rat kangaroo tissue culture cells as substrate. Anticentromere (Kinetochore) antibodies were present in 28 patients, and anticentriole antibodies were present in four patients. Anticentromere antibodies were usually present in patients with a benign, chronic form of systemic scleroderma, which has been termed the CREST (Calcinosis, Raynaud's phenomenon, esophageal involvement, sclerodactyly, and telangiectasia) syndrome. The four patients with a previously undescribed anticentriole antibody were all in the scleroderma spectrum. Possibly, these antibodies may have diagnostic and prognostic importance. Further, they will be useful in studying the structure and function of these cellular organelles.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6859899

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  37 in total

1.  MSA-36: a chromosomal and mitotic spindle-associated protein.

Authors:  J B Rattner; T Wang; G Mack; M J Fritzler; L Martin; D Valencia
Journal:  Chromosoma       Date:  1992-10       Impact factor: 4.316

2.  The nuclear-mitotic apparatus protein is important in the establishment and maintenance of the bipolar mitotic spindle apparatus.

Authors:  C H Yang; M Snyder
Journal:  Mol Biol Cell       Date:  1992-11       Impact factor: 4.138

Review 3.  Autoantibodies to components of the mitotic apparatus.

Authors:  J B Rattner; G J Mack; M J Fritzler
Journal:  Mol Biol Rep       Date:  1998-07       Impact factor: 2.316

4.  Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion.

Authors:  M Jarzabek-Chorzelska; M Blaszczyk; Z Kolacinska-Strasz; T Chorzelski; S Jabłońska; G G Maul
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

5.  Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.

Authors:  P J Maddison; R P Skinner; R S Pereira; C M Black; B M Ansell; M I Jayson; N R Rowell; K I Welsh
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

6.  Anticentromere antibody positive CREST syndrome associated with polyarthritis, renal impairment and mixed cryoglobulinaemia.

Authors:  H G Shetty; M M O'Sullivan; N Amos; B D Williams
Journal:  Clin Rheumatol       Date:  1989-09       Impact factor: 2.980

7.  Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma.

Authors:  W C Earnshaw; N Rothfield
Journal:  Chromosoma       Date:  1985       Impact factor: 4.316

8.  Use of cultured epithelial cells, including keratinocytes, for the detection of antinuclear antibodies.

Authors:  I Leigh; F Wojnarowska; S Burge; B Bhogal; T Zhu
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

9.  Anticytoskeletal autoantibody to microfilament anchorage sites recognizes novel focal contact proteins.

Authors:  J L Senécal; S Fortin; A Roussin; F Joyal
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

10.  Antinuclear antibodies in scleroderma, mixed connective tissue disease and "primary" Raynaud's phenomenon.

Authors:  M Cruz; G Mejia; C Lavalle; J J Cortes; P A Reyes
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.